People without diabetes who receive GLP-1 receptor agonists for the treatment of overweight or obesity face a reduced risk of developing dry age-related macular degeneration, a recent study shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1s-may-protect-against-amd-those-without-diabetes-2025a1000syv?src=rss
Author :
Publish date : 2025-10-24 07:01:00
Copyright for syndicated content belongs to the linked Source.
